<DOC>
	<DOC>NCT00240214</DOC>
	<brief_summary>The purpose of this study is to obtain data on the effectiveness and safety of Rapamune under everyday conditions</brief_summary>
	<brief_title>Study Evaluating Rapamune in Patients After Kidney Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients having received a renal allograft from a cadaveric or living donor with low or moderate risk of developing acute rejection episodes. Contraindications according to Summary of the Product Characteristics (SmPC).</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Kidney transplants</keyword>
</DOC>